Patryk Mikucki
Chief Tech/Sci/R&D Officer chez ALEXION PHARMACEUTICALS, INC.
Profil
Patryk Mikucki is currently working as the Vice President of Clinical Research at Alexion Pharmaceuticals, Inc. and as the Vice President at Astrazeneca Pharma Poland SP zoo.
He is also a Member of the Supervisory Board at Scope Fluidics SA. Dr. Mikucki has an MBA from the University of Illinois and a doctorate from the University of Life Sciences in Lublin.
Postes actifs de Patryk Mikucki
| Sociétés | Poste | Début |
|---|---|---|
| SCOPE FLUIDICS S.A. | Director/Board Member | 29/06/2018 |
| ALEXION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
| Astrazeneca Pharma Poland SP zoo | Corporate Officer/Principal | - |
Formation de Patryk Mikucki
| University of Illinois | Masters Business Admin |
| University of Life Sciences In Lublin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SCOPE FLUIDICS S.A. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
| Astrazeneca Pharma Poland SP zoo |
